MIRA
INFORM REPORT
|
Report Date : |
27.12.2007 |
IDENTIFICATION
DETAILS
|
Name : |
BIO ACTIVES JAPAN CORPORATION |
|
|
|
|
Registered Office : |
Kyoritsu Daisan Bldg 7F, 1-60-20 Minamiotsuka Toshimaku Tokyo 170-0005 |
|
|
|
|
Country : |
Japan |
|
|
|
|
Date of Incorporation : |
Sept 2006 |
|
|
|
|
Legal Form : |
Limited Company (Kabushiki Kaisha) |
|
|
|
|
Line of Business : |
Import, wholesale of natural
botanical extracts |
RATING &
COMMENTS
|
MIRA’s Rating : |
Ca |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
Status : |
Moderate |
|
|
|
|
Payment Behaviour : |
Regular |
name
BIO ACTIVES JAPAN CORPORATION
REGD NAME
KK Bio Actives Japan
MAIN OFFICE
Kyoritsu Daisan Bldg 7F, 1-60-20 Minamiotsuka Toshimaku Tokyo 170-0005
JAPAN
Tel : 03-5981-0601
Fax : 03-5981-0602
URL : http://www.bioactivesjapan.com/
E-Mail address: info@bioactivesjapan.com
ACTIVITIES
Import, wholesale of natural botanical extracts
BRANCHES
Nil
FACTORY(IES)
Higashi-Ikebukuro; India
OFFICER(S)
FAIZAL MOHAMMED, PRES (Indian resident)
Ikuko Yamazaki, PhD
Yen Amount: In
million Yen, unless otherwise stated
SUMMARY
FINANCES UNDETD A/SALES Yen 200 M*
PAYMENTS REGULAR CAPITAL Yen 0.5 M
TREND UNDETD WORTH Yen 0.5 M
STARTED 2006 EMPLOYES 3
* Sales targets for
the initial one-year term ending Aug 2007.
COMMENT
IMPORTER AND WHOLESALER SPECIALIZING IN NATURAL BOTANICAL
EXTRACTS. FINANCIAL SITUATION
UNDETERMINED DUE TO THE RECENT INCEPTION BUT SHOULD BE GOOD FOR MODERATE
BUSINESS ENGAGEMENTS.
MAX CREDIT LIMIT: UNABLE TO ASSESS IN THE ABSENCE OF PROVEN
BUSINESS. SECURED TERMS RECOMMENDED FOR
NEW TRANSACTIONS.
HIGHLIGHTS
The subject company was established as Japan marketing office by
Bio Actives, India, for marketing its products of natural botanical extracts as
mainline. This is a trading firm for
import and wholesale of natural botanical extracts from group firms in India
centrally, and USA. Clients are in the
areas of nutraceuticals, cosmetics and pharmaceutical industries.
FINANCIAL INFORMATION
The sales volume for the initial fiscal term ending Aug/2007
amounted to Yen 200 million, with breakeven profits basis, according to F
Mohammed. We have no data to verify
these figures.
Both the financial situation and business trends are not
determined due to the recent inception but should be good for MODERATE business
engagements. Max credit limits are yet
unable to be assessed due to the absence of proven business records.
REGISTRATION
Date Registered: Sept
2006
Legal Status: Limited
Company (Kabushiki Kaisha)
Authorized: 10
shares
Issued: 10
shares
Sum: Yen
500,000.00
Major shareholders (%): Faizal Mohammed (100)
Nothing detrimental is known as to his commercial morality.
OPERATION
Activities: Imports and wholesales natural botanical extracts,
beauty products, bio-technology products, enzyme (ferment), preparations,
health products, others (--100%).
Goods are imported from its
headquarters in India and other contracted facilities throughout India, and
USA.
Clients: Pharmaceutical, cosmetics, health foods mfrs, other.
No. of accounts: Unavailable
Domestic areas of activities: Nationwide
Suppliers: [Mfrs] Imports mainly from Astra Nutraceuticals
(Chennai, India), Bio Green Nutrachem Inc (USA), other.
Payment record: Regular
Location: Business area in Tokyo. Office premises at the caption address are leased and maintained
satisfactorily.
Bank References
State Bank of India (Tokyo)
MUFG (Tanashi-Ekimae)
Relations: Money deposits & transfers only
FINANCES
(In Million Yen)
NOT MADE AVAILABLE AS YET
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)